DK3004340T3 - Behandling af glutenintolerance og beslægtede tilstande - Google Patents

Behandling af glutenintolerance og beslægtede tilstande Download PDF

Info

Publication number
DK3004340T3
DK3004340T3 DK14763905.8T DK14763905T DK3004340T3 DK 3004340 T3 DK3004340 T3 DK 3004340T3 DK 14763905 T DK14763905 T DK 14763905T DK 3004340 T3 DK3004340 T3 DK 3004340T3
Authority
DK
Denmark
Prior art keywords
glutenen
intolerance
treatment
related conditions
conditions
Prior art date
Application number
DK14763905.8T
Other languages
English (en)
Inventor
David Schriemer
Petr Man
Hynek Mrazek
Martial Rey
Original Assignee
Codexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codexis Inc filed Critical Codexis Inc
Application granted granted Critical
Publication of DK3004340T3 publication Critical patent/DK3004340T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/63Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/23Aspartic endopeptidases (3.4.23)
    • C12Y304/23012Nepenthesin (3.4.23.12)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK14763905.8T 2012-11-21 2014-03-14 Behandling af glutenintolerance og beslægtede tilstande DK3004340T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261729210P 2012-11-21 2012-11-21
US201261797040P 2012-11-27 2012-11-27
US13/843,369 US9005610B2 (en) 2012-11-21 2013-03-15 Treatment of gluten intolerance and related conditions
PCT/CA2014/000258 WO2014138927A1 (en) 2012-11-21 2014-03-14 Treatment of gluten intolerance and related conditions

Publications (1)

Publication Number Publication Date
DK3004340T3 true DK3004340T3 (da) 2020-09-21

Family

ID=50728145

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14763905.8T DK3004340T3 (da) 2012-11-21 2014-03-14 Behandling af glutenintolerance og beslægtede tilstande

Country Status (15)

Country Link
US (7) US9005610B2 (da)
EP (1) EP2922568A1 (da)
JP (1) JP6412876B2 (da)
KR (1) KR102296428B1 (da)
CN (1) CN105007934B (da)
AU (1) AU2013350261B2 (da)
CA (1) CA2892474C (da)
DK (1) DK3004340T3 (da)
ES (1) ES2821771T3 (da)
HR (1) HRP20201459T1 (da)
HU (1) HUE050868T2 (da)
IL (2) IL238912B (da)
MX (2) MX2015006419A (da)
PT (1) PT3004340T (da)
WO (2) WO2014078935A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9005610B2 (en) 2012-11-21 2015-04-14 Nepetx, Llc Treatment of gluten intolerance and related conditions
JP6502269B2 (ja) * 2013-03-15 2019-04-17 ネプエトゥクス,エルエルシー グルテン不耐症および関連する状態の治療
CN106794228B (zh) 2014-06-16 2021-09-03 科德克希思公司 用于治疗麸质不耐受和由其引起的病症的组合物和方法
US10857214B2 (en) * 2015-12-16 2020-12-08 Codexis, Inc. Compositions and methods for treating gluten intolerance and disorders arising therefrom
US11549124B2 (en) 2017-09-20 2023-01-10 Aarhus Universitet Nepenthesin-1 derived resistance to fungal pathogens in major crop plants
EP3946394A4 (en) * 2019-04-02 2023-01-11 Sami-Sabinsa Group Limited METHOD AND COMPOSITION FOR THE THERAPEUTIC MANAGEMENT OF GLUTEN INTOLERANCE

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DK81193D0 (da) * 1993-07-06 1993-07-06 Novo Nordisk As Enzym
JP3767831B2 (ja) * 1995-06-14 2006-04-19 木村 健 ヘリコバクター・ピロリ除菌用組成物
JP3521635B2 (ja) 1996-08-07 2004-04-19 日本電信電話株式会社 映像生成方法および映像生成システム
JPH1149697A (ja) * 1997-08-01 1999-02-23 Nisshin Flour Milling Co Ltd ストレス抑制剤及びストレス抑制用食品
US7320788B2 (en) * 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
DK1572127T4 (da) 2002-02-14 2014-11-24 Univ Leland Stanford Junior Enzymbehandling af fødevarer til cøliaki
JP4415244B2 (ja) * 2003-02-21 2010-02-17 グリコ栄養食品株式会社 小麦蛋白質にプロテアーゼを限定的に作用させて得られる食品素材
US7628985B2 (en) 2004-04-26 2009-12-08 The Board Of Regents Of The Leland Stanford Junior University Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
US20060095096A1 (en) 2004-09-09 2006-05-04 Debenedictis Leonard C Interchangeable tips for medical laser treatments and methods for using same
US8119385B2 (en) 2005-03-04 2012-02-21 Bp Corporation North America Inc. Nucleic acids and proteins and methods for making and using them
EP1949093A2 (en) 2005-10-11 2008-07-30 Alvine Pharmaceuticals, Inc. Compositions and methods for enhanced gastrointestinal stability of oligopeptides and polypeptides
JP2009511040A (ja) * 2005-10-11 2009-03-19 モフィン エス.アール.エル. セリアック病患者のための、グルテンを含まない、ブルーベインの(blue−veined)日用製品
AU2007299219A1 (en) 2006-04-05 2008-03-27 Metanomics Gmbh Process for the production of a fine chemical
US8148105B2 (en) 2007-03-16 2012-04-03 The Board Of Trustees Of The Leland Stanford Junior University Scaleable manufacturing process for cysteine endoprotease B, isoform 2
EP2229404A4 (en) * 2007-12-10 2011-03-09 Univ Leland Stanford Junior ENZYMATIC POLYTHERAPY FOR GASTRIC DIGESTION OF FOOD GLUTEN IN PATIENTS WITH CELIAC DISEASE
WO2010021752A1 (en) 2008-08-21 2010-02-25 Alvine Pharmaceuticals, Inc. Formulation for oral administration of proteins
JP2011049697A (ja) 2009-08-25 2011-03-10 Panasonic Corp フリッカ検出装置、撮像装置、フリッカ検出プログラム、及び、フリッカ検出方法
US20110200574A1 (en) 2010-02-02 2011-08-18 Jolly James F Use of proteases for gluten intolerance
NZ603027A (en) 2010-03-30 2014-01-31 Alvine Pharmaceuticals Inc Proteases for degrading gluten
US9023345B2 (en) * 2011-03-01 2015-05-05 Novus International, Inc. Methods for improving gut health
US9005610B2 (en) 2012-11-21 2015-04-14 Nepetx, Llc Treatment of gluten intolerance and related conditions

Also Published As

Publication number Publication date
US10982201B2 (en) 2021-04-20
US20210230569A1 (en) 2021-07-29
HRP20201459T1 (hr) 2020-12-11
EP2922568A1 (en) 2015-09-30
HUE050868T2 (hu) 2021-01-28
US20140140980A1 (en) 2014-05-22
IL283484A (en) 2021-06-30
CA2892474C (en) 2022-06-21
US9745565B2 (en) 2017-08-29
US9623092B2 (en) 2017-04-18
AU2013350261B2 (en) 2018-12-06
US10266818B2 (en) 2019-04-23
US20150290301A1 (en) 2015-10-15
US20140186330A1 (en) 2014-07-03
US20170067040A1 (en) 2017-03-09
WO2014138927A1 (en) 2014-09-18
CA2892474A1 (en) 2014-05-30
US11725198B2 (en) 2023-08-15
IL238912B (en) 2021-06-30
MX2015006419A (es) 2015-12-15
US20200040322A1 (en) 2020-02-06
IL238912A0 (en) 2015-07-30
KR102296428B1 (ko) 2021-09-01
AU2013350261A1 (en) 2015-07-09
CN105007934B (zh) 2019-02-05
CN105007934A (zh) 2015-10-28
JP2016501853A (ja) 2016-01-21
MX2015011825A (es) 2016-05-31
US20150265686A1 (en) 2015-09-24
KR20150123783A (ko) 2015-11-04
US9005610B2 (en) 2015-04-14
WO2014078935A1 (en) 2014-05-30
JP6412876B2 (ja) 2018-10-24
PT3004340T (pt) 2020-09-30
ES2821771T3 (es) 2021-04-27

Similar Documents

Publication Publication Date Title
DK2882496T3 (da) Behandling og diagnosticering af melanom
DK2898061T3 (da) Probiotiske sammensætninger til behandlingen af fedme og fedme-relaterede tilstande
DK2958588T3 (da) Kombination af vaccination og hæmning af PD-1-reaktionsvejen
DK2968208T3 (da) Behandling af kataplexi
DK2882441T3 (da) Behandling af immunrelaterede og inflammatoriske sygdomme
DK2806892T3 (da) Kombineret terapeutisk anvendelse af antistoffer og endoglycosidaser
DK2929031T5 (da) Pcsk9-irna-sammensætninger og fremgangsmåder til anvendelse deraf
DK2691443T3 (da) Konjugerede lipomerer og anvendelser af disse
DK2846809T3 (da) Behandling af myelosuppression
DK2688557T3 (da) Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed
DK2919923T3 (da) Holder-sortiment og rengøringsapparater til rengøring af åndedrætsapparater
DK3076972T3 (da) Cancerbehandling med kombination af plinabulin og taxan
DK2776567T3 (da) Sammensætninger og fremgangsmåder til behandling af cytomegalovirus.
DK3021838T3 (da) Behandling af fedme
DK2723347T3 (da) Forebyggelse og behandling af inflammationstilstande
DK3685848T3 (da) Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension
DK2785349T3 (da) Kombinationsbehandling af cancer
DK3007695T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
DK3238707T3 (da) Sammensætninger og fremgangsmåder til behandling af intestinal hyperpermeabilitet
DK2964255T3 (da) Behandling og forebyggelse af fjerntliggende iskæmi-reperfusionsskade (IRI)
DK3083789T3 (da) Overfladebehandling af partikler og anvendelse heraf
DK3366307T3 (da) Sammensætninger og fremgangsmåder til inhibering af masp-1 og/eller masp-3 til behandling af paroxystisk nokturn hæmoglobinuri
DK2917181T3 (da) Heteroarylderivater og anvendelser deraf
DK2914261T3 (da) Syntetisk letalitet og behandling af cancer
DK3033081T3 (da) Sammensætninger og fremgangsmåder til behandling af kronisk urticaria